What are the causes of an increased blood urea nitrogen (BUN) level?

Causes of Elevated Blood Urea Nitrogen (BUN)

Elevated BUN results from either decreased renal clearance or increased urea production, with the most common causes being renal dysfunction, volume depletion, heart failure, gastrointestinal bleeding, high protein intake, and increased protein catabolism. 1, 2

Pathophysiologic Mechanisms

BUN elevation occurs through fundamentally different mechanisms than creatinine elevation, which explains why they may rise disproportionately:

• Urea is produced in the liver as a degradation product of proteins and is primarily filtered by the kidneys, but unlike creatinine, 40-50% of filtered urea is reabsorbed in the proximal tubule, paralleling sodium and water reabsorption. 2
• This reabsorption characteristic makes BUN levels sensitive to both renal function and volume status, whereas creatinine is freely filtered at the glomerulus but not reabsorbed, making it a more specific marker for glomerular filtration rate. 1, 2
• In states of decreased renal perfusion, enhanced reabsorption of urea occurs in the proximal tubules, while creatinine clearance may remain relatively stable. 1

Primary Clinical Causes

Decreased Renal Clearance

Acute kidney injury causes reduced glomerular filtration rate, leading to decreased urea clearance. 2

• Renal dysfunction is common in heart failure, and the prevalence increases with heart failure severity, age, history of hypertension, or diabetes. 3
• In heart failure, renal dysfunction is strongly linked to increased morbidity and mortality, with BUN being a better predictor of outcomes than creatinine or estimated GFR, reflecting both cardiac and renal dysfunction as well as neurohormonal activation. 3, 2
• Heart failure leads to reduced cardiac output, decreasing renal perfusion, and neurohormonal activation promotes fluid retention and renal vasoconstriction. 2

Volume Depletion and Prerenal States

Volume depletion is a common cause of disproportionate BUN elevation, with documented hypovolemia present in nearly half of intensive care patients with markedly elevated BUN. 4

• Intravascular volume depletion during hemodialysis can contribute to more rapid loss of residual kidney function and disproportionate BUN elevation. 1
• Congestive heart failure was present in approximately 40% of patients with massive BUN elevation, and septic or hypovolemic shock occurred in about one-third of cases. 4

Increased Protein Load or Catabolism

High protein intake exceeding 100 g/day contributes to BUN elevation, particularly in intensive care patients, and was present in approximately 40% of patients with severely disproportionate BUN elevation. 4

• Gastrointestinal bleeding causes BUN elevation through absorption of blood proteins in the gut, with BUN and the BUN-to-creatinine ratio remaining elevated or continuing to increase if bleeding persists. 1, 5
• High-dose corticosteroids increase protein catabolism and were documented in patients with massive BUN elevation. 4
• Sepsis and severe infection, present in approximately 75% of patients with disproportionate BUN elevation, cause hypercatabolic states that increase urea production. 4

Medication Effects

ACE inhibitors and ARBs cause BUN elevation through hemodynamic effects on glomerular filtration, with increases up to 50% above baseline (or up to 266 μmol/L or 3 mg/dL creatinine) considered acceptable. 3, 1, 2

• Therapy with an ACEI or ARB is usually associated with a mild deterioration in renal function as evidenced by some increase in blood urea nitrogen and creatinine levels, and these changes are frequently transient and reversible. 3
• A modest increase in BUN that is asymptomatic does not require discontinuation of ACE-inhibitor or ARB therapy, and these medications should only be stopped if creatinine rises by more than 100% from baseline or exceeds 310 μmol/L (3.5 mg/dL). 1

Special Populations and Clinical Contexts

Elderly Patients

Severely disproportionate BUN elevation is most common in the elderly (approximately 70% of cases occurring in patients over 75 years), likely due to their lower muscle mass resulting in lower baseline creatinine. 4

Critically Ill Patients

Disproportionate BUN elevation in intensive care patients is frequently multifactorial, with approximately 85% having two or more contributing factors, and mortality is high due to severe underlying illnesses, especially infection, worsened by decreased renal function and hypercatabolic state. 4

• Elevated BUN may be a risk factor for delirium in critically ill elderly patients without renal dysfunction, with odds ratios ranging from 1.35 to 1.39 in those with BUN levels exceeding 23 mg/dL. 6
• In patients with extensive burns, the blood urea nitrogen-to-albumin ratio demonstrates superior prognostic utility for 30-day and 60-day mortality compared to individual markers. 7

Heart Failure Patients

Persistent high BUN levels during hospitalization for acute heart failure are associated with increased risk of cardiovascular death and heart failure readmission, while normalization of BUN levels during hospitalization may be associated with improved long-term clinical outcomes. 8

Other Conditions

Patients with non-alcoholic fatty liver disease have significantly higher BUN compared to controls (5.04 vs. 4.13 mmol/L), which may indicate activation of the renin-angiotensin-aldosterone system and increased cardiovascular disease risk. 9

Laboratory and Sampling Considerations

Laboratory errors in BUN measurement can cause discrepancies and include dilution of predialysis sample with saline, drawing sample after dialysis has started, and laboratory calibration errors. 1, 2

• For individuals undergoing dialysis, blood for BUN and creatinine should be drawn before the start of the dialysis session to avoid artificial lowering caused by the procedure. 1
• Timing of sample collection is critical for accurate assessment, as drawing samples after dialysis has started lowers BUN through solute removal. 2

Clinical Pitfalls

Fractional sodium excretion less than 1% (consistent with prerenal azotemia) was present in only 36% of patients with severely disproportionate BUN elevation, indicating that elevated BUN is often not indicative of uncomplicated renal hypoperfusion even when low renal perfusion is present. 4

• The cause of renal dysfunction should always be sought to detect potentially reversible causes such as hypotension, dehydration, deterioration in renal function due to ACEIs or ARBs, other concomitant medications (e.g., NSAIDs), and renal artery stenosis. 3
• Avoid stopping guideline-directed medical therapies (ACE inhibitors, ARBs, SGLT2 inhibitors) prematurely for modest BUN elevations, as these provide long-term kidney protection. 1